Diaphorina citri psyllid: psy13963


Local Sequence Feature Prediction

Prediction and MethodResult
Residue Number Marker
Protein Sequence ?
Secondary Structure (Consensus) ?
Disordered Region (Consensus) ?
Transmembrane Helix (Consensus) ?
Signal Peptide (Consensus) ?
Coiled Coil (COILS) ?
 
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400--
MCTITTPFSSPPPGVFLSLLIFLSIAGNILVCAAIYTDRGLRRIGNLFLASLAIADLFVAALVMSFALVNDLLGYWMFGPQFCDTWIAFDVMCSTSSILNLCAISLDRYIHIKDPLRYSRWVTRKVAVGTIACIWLLAALISFVPISLGLHRPPVPVELYEGELPTCALDLTPTYAVVSSCISFYVPCIVMLGIYLRLYCYAQKHVKSIRAVTRPLPSSSSLPRPSPALHITTTSSPYHVSDHKAAITVGVIMGTFLLCWVPFFCVNIIAAFCKTCIPGYWFKILTWLGYSNSAFNPIIYSIYNKEFRDAFKRILITNYAASTAYTCCLCYVCCRGDAYAAGGDFRDYAATSRGAGFGASGDWDLGGGGKVGNSNNNNYSDYVHVEGMEEKRQNSMVETKQI
cccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccHHHHHHHHHHHHHHHHHHccHHHHHHHccccccccccHHHHHHHHHHHcHHHHHHHHHHHHHHHHHccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccCEcccccEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHcHHHHHHHHHHHHccccccHHHHHHHHHHHcccccccHHHHccccHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHccccccccc
*******FSSPPPGVFLSLLIFLSIAGNILVCAAIYTDRGLRRIGNLFLASLAIADLFVAALVMSFALVNDLLGYWMFGPQFCDTWIAFDVMCSTSSILNLCAISLDRYIHIKDPLRYSRWVTRKVAVGTIACIWLLAALISFVPISLGLHRPPVPVELYEGELPTCALDLTPTYAVVSSCISFYVPCIVMLGIYLRLYCYAQKHVKSIRAV*************************YHVSDHKAAITVGVIMGTFLLCWVPFFCVNIIAAFCKTCIPGYWFKILTWLGYSNSAFNPIIYSIYNKEFRDAFKRILITNYAAST*******************************************************************************
xxxxxxxxxxxxxxHHHHHHHHHHHHHHHHHHHHHHxxxxxxxxxHHHHHHHHHHHHHHHHHHHHHHHHxxxxxxxxxxxxxxxxHHHHHHHHHHHHHHHHHHHHxxxxxxxxxxxxxxxxxxxxHHHHHHHHHHHHHHHHHHHHHHHxxxxxxxxxxxxxxxxxxxxxxxxxxHHHHHHHHHHHHHHHHHHHHHHxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxHHHHHHHHHHHHHHHHHHHHHHHHxxxxxxxxHHHHHHHHHHHHHHHHHHHHHHHxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
MCTITTPFSSPPPGVFLSLLIFLSIAGNILVCAAIYTDRGLRRIGNLFLASLAIADLFVAALVMSFALVNDLLGYWMFGPQFCDTWIAFDVMCSTSSILNLCAISLDRYIHIKDPLRYSRWVTRKVAVGTIACIWLLAALISFVPISLGLHRPPVPVELYEGELPTCALDLTPTYAVVSSCISFYVPCIVMLGIYLRLYCYAQKHVKSIRAVTRPLPSSSSLPRPSPALHITTTSSPYHVSDHKAAITVGVIMGTFLLCWVPFFCVNIIAAFCKTCIPGYWFKILTWLGYSNSAFNPIIYSIYNKEFRDAFKRILITNYAASTAYTCCLCYVCCRGDAYAAGGDFRDYAATSRGAGFGASGDWDLGGGGKVGNSNNNNYSDYVHVEGMEEKRQNSMVETKQI

Function Prediction

Annotation transfered from Closely Related SWISS-PROT Entries ?

Annotation ?Function Description ?Confidence Level ?Reference Protein ?
Dopamine receptor 1 Receptor for dopamine. The activity of this receptor is mediated by G proteins which activate adenylyl cyclase. Might be involved in the processing of visual information and/or visual learning. Important for Pavlovian conditioning: required in the mushroom body as a receptor conveying unconditional stimuli information, has a role in memory formation for aversive and appetitive learning. Sleep-deprivation-induced impairments in learning can be partially explained through alterations in dopamine signaling, DopR expression levels are reduced; sleep may have a role in restoring dopamine homeostasis.confidentP41596
D(1B) dopamine receptor Dopamine receptor whose activity is mediated by G proteins which activate adenylyl cyclase.confidentP25115
D(1A) dopamine receptor Dopamine receptor whose activity is mediated by G proteins which activate adenylyl cyclase.confidentP21728

Prediction of Gene Ontology Terms ?

GO Term ?Description ?Confidence Level ?Parent GO Terms ?
GO:0004993 [MF]serotonin receptor activityprobableGO:0004930, GO:0038023, GO:0060089, GO:0004888, GO:0003674, GO:0004872, GO:0004871, GO:0008227
GO:0007191 [BP]adenylate cyclase-activating dopamine receptor signaling pathwayprobableGO:0065007, GO:0044700, GO:0051716, GO:0008150, GO:0007212, GO:0050896, GO:0009987, GO:0050794, GO:0023052, GO:0050789, GO:0007188, GO:0007189, GO:0044763, GO:0007165, GO:0007166, GO:0007154, GO:0007186, GO:0007187, GO:0044699
GO:0071329 [BP]cellular response to sucrose stimulusprobableGO:1901700, GO:1901701, GO:0009744, GO:0009743, GO:0034285, GO:0071322, GO:0050896, GO:0009987, GO:0051716, GO:0071324, GO:0008150, GO:0071310, GO:0044763, GO:0070887, GO:0042221, GO:0010033, GO:0044699
GO:0034776 [BP]response to histamineprobableGO:0009719, GO:0050896, GO:0060359, GO:0010243, GO:0010033, GO:0008150, GO:0042221, GO:1901698, GO:0014070
GO:0008284 [BP]positive regulation of cell proliferationprobableGO:0042127, GO:0050794, GO:0065007, GO:0048518, GO:0008150, GO:0050789, GO:0048522
GO:0044710 [BP]single-organism metabolic processprobableGO:0008150, GO:0008152
GO:0045664 [BP]regulation of neuron differentiationprobableGO:0030154, GO:0007275, GO:0044699, GO:0050767, GO:0048869, GO:0060284, GO:0050789, GO:0008150, GO:0065007, GO:0032502, GO:0032501, GO:0050793, GO:0009987, GO:0050794, GO:0045595, GO:0044763, GO:0051239, GO:0022008, GO:0048699, GO:0007399, GO:0044707, GO:0048856, GO:0051960, GO:2000026, GO:0048731
GO:0005929 [CC]ciliumprobableGO:0043231, GO:0044464, GO:0005623, GO:0005622, GO:0005575, GO:0043229, GO:0044424, GO:0042995, GO:0043227, GO:0043226
GO:0002027 [BP]regulation of heart rateprobableGO:0044057, GO:0008016, GO:0008150, GO:0051239, GO:0065007, GO:0065008, GO:0050789
GO:0031398 [BP]positive regulation of protein ubiquitinationprobableGO:0032268, GO:0009893, GO:0080090, GO:0060255, GO:0051246, GO:0031325, GO:0031401, GO:0031323, GO:0051247, GO:0050794, GO:0008150, GO:0048518, GO:0032270, GO:0031399, GO:0031396, GO:0065007, GO:0019222, GO:0010604, GO:0050789, GO:0048522
GO:0010765 [BP]positive regulation of sodium ion transportprobableGO:0010959, GO:0051050, GO:0051049, GO:0043270, GO:0065007, GO:0002028, GO:0048518, GO:0008150, GO:0032879, GO:0050789, GO:0043269
GO:0007210 [BP]serotonin receptor signaling pathwayprobableGO:0044700, GO:0051716, GO:0008150, GO:0050896, GO:0009987, GO:0050794, GO:0023052, GO:0065007, GO:0044763, GO:0007165, GO:0007166, GO:0007154, GO:0007186, GO:0050789, GO:0044699
GO:0042391 [BP]regulation of membrane potentialprobableGO:0019725, GO:0050801, GO:0009987, GO:0006873, GO:0048878, GO:0042592, GO:0065007, GO:0044763, GO:0008150, GO:0055082, GO:0065008, GO:0044699
GO:0035625 [BP]epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathwayprobableGO:0019220, GO:0009893, GO:0019222, GO:0033674, GO:0010647, GO:0048584, GO:0048583, GO:0042058, GO:0023056, GO:0031399, GO:0023052, GO:0007165, GO:0007166, GO:0023051, GO:1901186, GO:1901184, GO:0010646, GO:0050789, GO:0044699, GO:0080090, GO:0051716, GO:0051347, GO:0045937, GO:0048522, GO:0009966, GO:0009967, GO:0010562, GO:0043549, GO:0051246, GO:0051247, GO:0045742, GO:0043085, GO:0044093, GO:0061097, GO:0061098, GO:0065007, GO:0065009, GO:0010469, GO:0048518, GO:2000273, GO:0045859, GO:0035624, GO:0060255, GO:0031323, GO:0045741, GO:0050794, GO:0051174, GO:0007176, GO:0032268, GO:0044763, GO:0007154, GO:0010604, GO:0042325, GO:0044700, GO:0042327, GO:0001932, GO:0050790, GO:0050731, GO:0007186, GO:0050896, GO:0031401, GO:0051338, GO:0031325, GO:0050730, GO:0008150, GO:0009987, GO:0045860, GO:0001934, GO:0032270
GO:0007190 [BP]activation of adenylate cyclase activityprobableGO:0019220, GO:0031281, GO:0019222, GO:0031328, GO:0031326, GO:0031325, GO:0031323, GO:0051339, GO:0045981, GO:0043085, GO:0009893, GO:0030819, GO:0030816, GO:0045761, GO:0045762, GO:0009891, GO:0030810, GO:0050789, GO:0065007, GO:0044093, GO:0051349, GO:0048518, GO:0065009, GO:0045935, GO:0045937, GO:0019219, GO:0050790, GO:0009889, GO:0050794, GO:0051174, GO:1900542, GO:0008150, GO:0051171, GO:0051173, GO:0030799, GO:0031279, GO:1900544, GO:1900371, GO:0030808, GO:0080090, GO:0030804, GO:0030801, GO:1900373, GO:0030802, GO:0030817, GO:0006140, GO:0030814, GO:0010562, GO:0048522
GO:0007193 [BP]adenylate cyclase-inhibiting G-protein coupled receptor signaling pathwayprobableGO:0044700, GO:0051716, GO:0008150, GO:0050896, GO:0009987, GO:0050794, GO:0023052, GO:0050789, GO:0007188, GO:0065007, GO:0044763, GO:0007165, GO:0007166, GO:0007154, GO:0007186, GO:0007187, GO:0044699
GO:0007194 [BP]negative regulation of adenylate cyclase activityprobableGO:0010563, GO:0031280, GO:0080090, GO:0019222, GO:0031327, GO:0051350, GO:0031324, GO:0031323, GO:0009892, GO:1900371, GO:0045980, GO:0043086, GO:0019220, GO:0009890, GO:0030818, GO:0045761, GO:0030814, GO:0030815, GO:0050789, GO:0065007, GO:0044092, GO:0048519, GO:0065009, GO:0045934, GO:0045936, GO:0019219, GO:0050790, GO:0009889, GO:0050794, GO:0031326, GO:1900542, GO:0008150, GO:0051171, GO:0051172, GO:0030799, GO:0031279, GO:0051174, GO:1900543, GO:0030802, GO:0030809, GO:0030808, GO:1900372, GO:0030800, GO:0030803, GO:0051339, GO:0030817, GO:0006140, GO:0048523
GO:0030018 [CC]Z discprobableGO:0005737, GO:0005575, GO:0043229, GO:0043232, GO:0044464, GO:0031674, GO:0005623, GO:0005622, GO:0030016, GO:0030017, GO:0044444, GO:0043228, GO:0043292, GO:0044424, GO:0043226, GO:0044422, GO:0044449
GO:0002032 [BP]desensitization of G-protein coupled receptor protein signaling pathway by arrestinprobableGO:0048585, GO:0022401, GO:0048583, GO:0051100, GO:0023057, GO:0008277, GO:0010648, GO:0023051, GO:0010646, GO:0050789, GO:0023058, GO:0032091, GO:0009968, GO:0009966, GO:0045744, GO:0065007, GO:0044092, GO:0048519, GO:0065009, GO:0002029, GO:0050794, GO:0043393, GO:0051098, GO:0008150, GO:0048523
GO:0048545 [BP]response to steroid hormone stimulusprobableGO:0009719, GO:0033993, GO:0050896, GO:0008150, GO:0009725, GO:0042221, GO:0010033, GO:0014070
GO:0050482 [BP]arachidonic acid secretionprobableGO:0006869, GO:0046717, GO:0006820, GO:0015718, GO:0044699, GO:1901571, GO:0071702, GO:0033036, GO:0015909, GO:0015908, GO:0015849, GO:0006811, GO:0006810, GO:0015711, GO:0044765, GO:0008150, GO:0051234, GO:0010876, GO:0051179, GO:0046942, GO:0046903, GO:0071715, GO:0032309
GO:0051128 [BP]regulation of cellular component organizationprobableGO:0008150, GO:0065007, GO:0050789, GO:0050794
GO:0007202 [BP]activation of phospholipase C activityprobableGO:0051336, GO:0060193, GO:0060191, GO:0019222, GO:0051345, GO:0050790, GO:0050789, GO:0010518, GO:1900274, GO:0065007, GO:0043085, GO:0044093, GO:0008150, GO:0010863, GO:0065009, GO:0010517
GO:0051047 [BP]positive regulation of secretionprobableGO:0051046, GO:0051050, GO:0051049, GO:0065007, GO:0048518, GO:0008150, GO:0032879, GO:0050789
GO:0032412 [BP]regulation of ion transmembrane transporter activityprobableGO:0022898, GO:0050794, GO:0008150, GO:0032409, GO:0065007, GO:0034762, GO:0051049, GO:0034765, GO:0065009, GO:0032879, GO:0050789, GO:0043269
GO:0040040 [BP]thermosensory behaviorprobableGO:0009628, GO:0044702, GO:0044704, GO:0019098, GO:0044708, GO:0050896, GO:0007610, GO:0022414, GO:0008150, GO:0009266, GO:0044699, GO:0000003
GO:0003059 [BP]positive regulation of the force of heart contraction by epinephrineprobableGO:0003013, GO:0008217, GO:0050789, GO:0044699, GO:0003099, GO:0003057, GO:0044057, GO:0051240, GO:0003321, GO:0002026, GO:0065007, GO:0048518, GO:0065008, GO:0032501, GO:0003073, GO:0008015, GO:0003008, GO:0008016, GO:0008150, GO:0051239, GO:0001993, GO:0001997, GO:0003044, GO:0044707, GO:0045777, GO:0045823
GO:0097195 [BP]pilomotor reflexprobableGO:0008150, GO:0050896, GO:0060004, GO:0009605
GO:0042594 [BP]response to starvationprobableGO:0009991, GO:0009605, GO:0050896, GO:0031667, GO:0006950, GO:0008150
GO:0006796 [BP]phosphate-containing compound metabolic processprobableGO:0009987, GO:0008150, GO:0008152, GO:0044237, GO:0006793
GO:0050728 [BP]negative regulation of inflammatory responseprobableGO:0032102, GO:0032101, GO:0048585, GO:0048583, GO:0050727, GO:0050789, GO:0008150, GO:0031348, GO:0065007, GO:0048519, GO:0080134, GO:0031347
GO:0006937 [BP]regulation of muscle contractionprobableGO:0044057, GO:0008150, GO:0090257, GO:0051239, GO:0065007, GO:0050789
GO:0008179 [MF]adenylate cyclase bindingprobableGO:0003674, GO:0005515, GO:0019899, GO:0005488
GO:0032403 [MF]protein complex bindingprobableGO:0003674, GO:0005488, GO:0005515
GO:0043197 [CC]dendritic spineprobableGO:0044309, GO:0044463, GO:0044464, GO:0030425, GO:0005575, GO:0097458, GO:0005623, GO:0043005, GO:0042995
GO:0048513 [BP]organ developmentprobableGO:0032502, GO:0032501, GO:0044707, GO:0048856, GO:0008150, GO:0048731, GO:0007275, GO:0044699
GO:0006816 [BP]calcium ion transportprobableGO:0072511, GO:0006812, GO:0006811, GO:0006810, GO:0008150, GO:0044765, GO:0030001, GO:0070838, GO:0051234, GO:0051179, GO:0044699
GO:0008306 [BP]associative learningprobableGO:0032501, GO:0044707, GO:0050877, GO:0050896, GO:0050890, GO:0007610, GO:0007611, GO:0008150, GO:0044699, GO:0044708, GO:0007612, GO:0003008
GO:0042803 [MF]protein homodimerization activityprobableGO:0046983, GO:0003674, GO:0005515, GO:0042802, GO:0005488
GO:0016482 [BP]cytoplasmic transportprobableGO:0009987, GO:0046907, GO:0006810, GO:0044763, GO:0051649, GO:0008150, GO:0051234, GO:0051179, GO:0044699, GO:0051641
GO:0045909 [BP]positive regulation of vasodilationprobableGO:0044057, GO:0051240, GO:0065007, GO:0051239, GO:0048518, GO:0008150, GO:0042312, GO:0050789
GO:0005794 [CC]Golgi apparatusprobableGO:0005737, GO:0043231, GO:0044464, GO:0043229, GO:0005623, GO:0005622, GO:0005575, GO:0044444, GO:0044424, GO:0043227, GO:0043226
GO:0005791 [CC]rough endoplasmic reticulumprobableGO:0005737, GO:0005783, GO:0044464, GO:0043229, GO:0005623, GO:0005622, GO:0005575, GO:0044444, GO:0044424, GO:0043227, GO:0043226, GO:0043231
GO:0031965 [CC]nuclear membraneprobableGO:0005575, GO:0005635, GO:0031090, GO:0005634, GO:0016020, GO:0044464, GO:0031967, GO:0031975, GO:0044446, GO:0043229, GO:0044428, GO:0012505, GO:0044424, GO:0005623, GO:0005622, GO:0043227, GO:0043226, GO:0044422, GO:0043231
GO:0050709 [BP]negative regulation of protein secretionprobableGO:0070201, GO:0032879, GO:0050708, GO:0051046, GO:0051051, GO:0051048, GO:0051049, GO:0060341, GO:0050794, GO:0008150, GO:0065007, GO:0048519, GO:0051223, GO:0051224, GO:0050789, GO:0048523, GO:0032880
GO:0004938 [MF]alpha2-adrenergic receptor activityprobableGO:0004930, GO:0004936, GO:0004935, GO:0060089, GO:0004888, GO:0003674, GO:0004872, GO:0004871, GO:0038023, GO:0008227
GO:0045597 [BP]positive regulation of cell differentiationprobableGO:0051094, GO:0050793, GO:0050794, GO:0045595, GO:0065007, GO:0048518, GO:0008150, GO:0050789, GO:0048522
GO:0005887 [CC]integral to plasma membraneprobableGO:0031226, GO:0016021, GO:0016020, GO:0044464, GO:0005623, GO:0005575, GO:0071944, GO:0005886, GO:0044425, GO:0044459, GO:0031224
GO:0043204 [CC]perikaryonprobableGO:0044464, GO:0044297, GO:0005623, GO:0005575, GO:0097458, GO:0043025
GO:0042321 [BP]negative regulation of circadian sleep/wake cycle, sleepprobableGO:0048585, GO:0048583, GO:0007610, GO:0042745, GO:0050789, GO:0042749, GO:0051241, GO:0048511, GO:0048512, GO:0065007, GO:0048519, GO:0007623, GO:0007622, GO:0050795, GO:0042752, GO:0045187, GO:0008150, GO:0022410, GO:0051239, GO:0044708, GO:0050896, GO:0042754, GO:0048521
GO:0097305 [BP]response to alcoholprobableGO:1901700, GO:0042221, GO:0050896, GO:0008150, GO:0010033
GO:0008144 [MF]drug bindingprobableGO:0003674, GO:0005488
GO:0051378 [MF]serotonin bindingprobableGO:0043169, GO:0097159, GO:0043167, GO:0003674, GO:0005488, GO:0043176, GO:1901363
GO:0051379 [MF]epinephrine bindingprobableGO:1901338, GO:0003674, GO:0005488, GO:0097159
GO:0032148 [BP]activation of protein kinase B activityprobableGO:0019220, GO:0009893, GO:0019222, GO:0033674, GO:0031325, GO:0031323, GO:0032147, GO:0045860, GO:0050789, GO:0043085, GO:0080090, GO:0051347, GO:0010604, GO:0010562, GO:0043549, GO:0051246, GO:0051247, GO:0032270, GO:0044093, GO:0031399, GO:0048518, GO:0065007, GO:0065009, GO:0050790, GO:0045937, GO:0060255, GO:0045859, GO:0050794, GO:0051174, GO:0008150, GO:0042325, GO:0042327, GO:0032268, GO:0031401, GO:0051338, GO:0001932, GO:0001934, GO:0048522
GO:0016023 [CC]cytoplasmic membrane-bounded vesicleprobableGO:0005737, GO:0031982, GO:0031410, GO:0044464, GO:0044444, GO:0005623, GO:0031988, GO:0005575, GO:0043229, GO:0044424, GO:0005622, GO:0043227, GO:0043226, GO:0043231
GO:0043235 [CC]receptor complexprobableGO:0043234, GO:0005575, GO:0032991
GO:0004989 [MF]octopamine receptor activityprobableGO:0004930, GO:0038023, GO:0060089, GO:0004888, GO:0003674, GO:0004872, GO:0004871, GO:0008227
GO:0035240 [MF]dopamine bindingprobableGO:0043169, GO:0097159, GO:0043167, GO:0003674, GO:0005488, GO:1901338
GO:0042493 [BP]response to drugprobableGO:0042221, GO:0050896, GO:0008150
GO:0051380 [MF]norepinephrine bindingprobableGO:1901338, GO:0003674, GO:0005488, GO:0097159
GO:0007268 [BP]synaptic transmissionprobableGO:0044700, GO:0019226, GO:0032501, GO:0044707, GO:0035637, GO:0050877, GO:0009987, GO:0008150, GO:0044763, GO:0023052, GO:0007267, GO:0007154, GO:0044699, GO:0003008
GO:0043679 [CC]axon terminusprobableGO:0044306, GO:0044463, GO:0044464, GO:0005623, GO:0030424, GO:0005575, GO:0097458, GO:0043005, GO:0033267, GO:0042995
GO:0044238 [BP]primary metabolic processprobableGO:0008150, GO:0008152
GO:0019637 [BP]organophosphate metabolic processprobableGO:0009987, GO:0044237, GO:0071704, GO:0008150, GO:0008152, GO:0006793
GO:0004941 [MF]beta2-adrenergic receptor activityprobableGO:0004930, GO:0038023, GO:0004935, GO:0004939, GO:0060089, GO:0004888, GO:0003674, GO:0004872, GO:0004871, GO:0008227
GO:0019933 [BP]cAMP-mediated signalingprobableGO:0044700, GO:0051716, GO:0008150, GO:0050896, GO:0009987, GO:0050794, GO:0023052, GO:0019935, GO:0065007, GO:0044763, GO:0007165, GO:0019932, GO:0007154, GO:0035556, GO:0050789, GO:0044699
GO:0044456 [CC]synapse partprobableGO:0005575, GO:0045202
GO:0045944 [BP]positive regulation of transcription from RNA polymerase II promoterprobableGO:0009893, GO:0019222, GO:0031328, GO:0031326, GO:0031325, GO:2001141, GO:0031323, GO:0010628, GO:0050789, GO:0080090, GO:0010604, GO:0051171, GO:0009891, GO:2000112, GO:0019219, GO:0010556, GO:0065007, GO:0048518, GO:0010468, GO:0045935, GO:0060255, GO:0009889, GO:0050794, GO:0008150, GO:0045893, GO:0051173, GO:0051252, GO:0051254, GO:0006355, GO:0010557, GO:0006357, GO:0048522
GO:0016324 [CC]apical plasma membraneprobableGO:0045177, GO:0016020, GO:0044464, GO:0005623, GO:0005575, GO:0071944, GO:0005886, GO:0044425, GO:0044459
GO:0032229 [BP]negative regulation of synaptic transmission, GABAergicprobableGO:0010646, GO:0044057, GO:0050794, GO:0031644, GO:0031645, GO:0051241, GO:0050805, GO:0050804, GO:0008150, GO:0023057, GO:0065007, GO:0010648, GO:0051239, GO:0023051, GO:0048519, GO:0051969, GO:0032228, GO:0051970, GO:0050789, GO:0048523
GO:0071883 [BP]activation of MAPK activity by adrenergic receptor signaling pathwayprobableGO:0000187, GO:0019220, GO:0009893, GO:0019222, GO:0033674, GO:0031325, GO:0048584, GO:0048583, GO:0032147, GO:0023056, GO:0043406, GO:0043405, GO:0023052, GO:0007165, GO:0007166, GO:0023051, GO:0071902, GO:0010647, GO:0071900, GO:0010627, GO:0050789, GO:0044699, GO:0043408, GO:0051716, GO:0010646, GO:0051347, GO:0010604, GO:0009966, GO:0009967, GO:0010562, GO:0043549, GO:0051246, GO:0051247, GO:0032270, GO:0043085, GO:0044093, GO:0031399, GO:0048518, GO:0065007, GO:0051174, GO:0010740, GO:0050790, GO:0045937, GO:0060255, GO:0031323, GO:0045859, GO:0080090, GO:0050794, GO:0043410, GO:0071875, GO:0032268, GO:0044763, GO:0007154, GO:0065009, GO:0042325, GO:0044700, GO:0042327, GO:0001932, GO:0007186, GO:0050896, GO:0031401, GO:0051338, GO:0008150, GO:0009987, GO:0045860, GO:0001934, GO:0048522
GO:0030315 [CC]T-tubuleprobableGO:0042383, GO:0016020, GO:0044464, GO:0005623, GO:0005575, GO:0071944, GO:0005886, GO:0044425, GO:0044459
GO:0002086 [BP]diaphragm contractionprobableGO:0050881, GO:0032501, GO:0006936, GO:0044707, GO:0050879, GO:0007585, GO:0006941, GO:0003011, GO:0003012, GO:0008150, GO:0044699, GO:0003016, GO:0003009, GO:0003008
GO:0005768 [CC]endosomeprobableGO:0005737, GO:0043231, GO:0044464, GO:0043229, GO:0005623, GO:0005622, GO:0005575, GO:0044444, GO:0044424, GO:0043227, GO:0043226
GO:0007613 [BP]memoryprobableGO:0032501, GO:0044707, GO:0044708, GO:0050896, GO:0050890, GO:0007610, GO:0007611, GO:0008150, GO:0050877, GO:0044699, GO:0003008
GO:0044260 [BP]cellular macromolecule metabolic processprobableGO:0009987, GO:0044237, GO:0043170, GO:0071704, GO:0008150, GO:0008152
GO:0006898 [BP]receptor-mediated endocytosisprobableGO:0006897, GO:0016192, GO:0006810, GO:0008150, GO:0051234, GO:0051179
GO:0046982 [MF]protein heterodimerization activityprobableGO:0046983, GO:0003674, GO:0005488, GO:0005515
GO:0043271 [BP]negative regulation of ion transportprobableGO:0051051, GO:0051049, GO:0008150, GO:0065007, GO:0048519, GO:0032879, GO:0050789, GO:0043269
GO:0043052 [BP]thermotaxisprobableGO:0040011, GO:0009628, GO:0042330, GO:0009605, GO:0050896, GO:0008150, GO:0009266
GO:0051924 [BP]regulation of calcium ion transportprobableGO:0051049, GO:0010959, GO:0065007, GO:0008150, GO:0032879, GO:0050789, GO:0043269
GO:0004952 [MF]dopamine neurotransmitter receptor activityprobableGO:0004930, GO:0030594, GO:0038023, GO:0060089, GO:0004888, GO:0003674, GO:0004872, GO:0004871
GO:0032809 [CC]neuronal cell body membraneprobableGO:0044298, GO:0043025, GO:0016020, GO:0044297, GO:0005623, GO:0044464, GO:0005575, GO:0097458, GO:0071944, GO:0005886, GO:0044425, GO:0044459
GO:0015459 [MF]potassium channel regulator activityprobableGO:0016247, GO:0003674
GO:0043268 [BP]positive regulation of potassium ion transportprobableGO:0010959, GO:0051050, GO:0051049, GO:0043270, GO:0043266, GO:0065007, GO:0048518, GO:0008150, GO:0032879, GO:0050789, GO:0043269
GO:0035811 [BP]negative regulation of urine volumeprobableGO:0032501, GO:0050878, GO:0044707, GO:0008150, GO:0035809, GO:0003014, GO:0065007, GO:0065008, GO:0044699, GO:0003008
GO:0051482 [BP]elevation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathwayprobableGO:0050801, GO:0042592, GO:0023052, GO:0007165, GO:0007166, GO:0050789, GO:0044699, GO:0072507, GO:0051716, GO:0072503, GO:0065007, GO:0065008, GO:0007186, GO:0019725, GO:0006875, GO:0006874, GO:0009987, GO:0006873, GO:0050794, GO:0044763, GO:0030003, GO:0055065, GO:0055080, GO:0007154, GO:0055082, GO:0044700, GO:0051480, GO:0007200, GO:0050896, GO:0007204, GO:0048878, GO:0008150, GO:0055074
GO:0007568 [BP]agingprobableGO:0044767, GO:0032502, GO:0008150, GO:0044699

Prediction of Enzyme Commission Number ?

No EC number assigned to the protein, probably not an enzyme!


Spatial Structural Prediction

Structural Models Based on Templates

Template: 3RZE, chain A
Confidence level:very confident
Coverage over the Query: 11-150,162-317
View the alignment between query and template
View the model in PyMOL